A 26-week randomised, controlled, open label, multicentre, multinational, treat to target trial investigating the impact of dietary intervention on weight change and the relationship between weight change and baseline body mass index (BMI) in subjects with type 2 diabetes inadequately controlled on oral antidiabetic drugs (OADs) initiating insulin therapy with insulin detemir in combination with metformin
Latest Information Update: 08 Oct 2021
At a glance
- Drugs Insulin detemir (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DIET
- Sponsors Novo Nordisk
- 17 Apr 2012 Actual end date changed from 15 Aug 2011 to 14 Nov 2011 as reported by European Clinical Trials Database record.
- 17 Apr 2012 Additional location (Germany) added as reported by European Clinical Trials Database record.
- 14 Mar 2012 New trial record